CCL18 and ovarian benign neoplasm: Schutyser et al.36determined that the expression level of CCL18 in patients with EOC and ascites was higher than that of patients with benign ovarian tumors with high immunostaining in the interstitial area and a limited number of CCL18 antibodies.